Literature DB >> 2948319

Percutaneous transluminal coronary angioplasty--histopathological analysis of nine necropsy cases.

C F de Morais, E A Lopes, H Checchi, S Arie, F Pileggi.   

Abstract

From 1982 to 1984 nine of 300 patients undergoing transluminal coronary angioplasty died. The nine coronary arteries and one saphenous aorto-coronary by-pass graft affected by angioplasty were studied by light microscopy. The following types of lesions were found, frequently in association: rupture of the plaque, circumscribed or reaching to the intimal layer or extending beyond it, dissections (fissures) between arterial layers, intra-plaque haemorrhage, plaque emboli and thrombosis. In two cases the therapeutic approach was considered to be clinically and pathologically successful; the patients survived 24 h (case 6) and forty days (case 4). Case 6 which presented recent lesions indicative of success showed, in contrast with the other non-successful cases, rupture affecting not only the intimal layer but also deeper structures of the arterial wall. There were also more extensive fissures. Case 4 which presented late alterations indicative of success showed a plaque fracture whose borders were kept apart by fibrous tissue. In conclusion, we believe that angioplasty allows the re-establishment of arterial blood flow by provoking deep intimal and medial rupture producing a small fissure between the arterial layers and a widening of the lumen; in cases with good late results these alterations cicatrize leaving a wider arterial lumen.

Entities:  

Mesh:

Year:  1986        PMID: 2948319     DOI: 10.1007/bf00710825

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  13 in total

1.  TRANSLUMINAL TREATMENT OF ARTERIOSCLEROTIC OBSTRUCTION. DESCRIPTION OF A NEW TECHNIC AND A PRELIMINARY REPORT OF ITS APPLICATION.

Authors:  C T DOTTER; M P JUDKINS
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

2.  Pathological findings after percutaneous transluminal coronary angioplasty.

Authors:  K Mizuno; A Kurita; N Imazeki
Journal:  Br Heart J       Date:  1984-11

Review 3.  Percutaneous transluminal coronary angioplasty. A review of the literature.

Authors:  J Z Przybojewski; H F Weich
Journal:  S Afr Med J       Date:  1984-01-25

4.  Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.

Authors:  C E Essed; M Van den Brand; A E Becker
Journal:  Br Heart J       Date:  1983-04

5.  Morphology after transluminal angioplasty in human beings.

Authors:  P C Block; R K Myler; S Stertzer; J T Fallon
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

6.  Arterial pathology after percutaneous transluminal angioplasty.

Authors:  M A Hoffman; J T Fallon; A J Greenfield; A C Waltman; C A Athanasoulis; P C Block
Journal:  AJR Am J Roentgenol       Date:  1981-07       Impact factor: 3.959

7.  Transluminal coronary angioplasty of postmortem human hearts.

Authors:  K L Baughman; R C Pasternak; J T Fallon; P C Block
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

8.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

Authors:  A R Grüntzig; A Senning; W E Siegenthaler
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

9.  Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.

Authors:  P C Block; K L Baughman; R C Pasternak; J T Fallon
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

10.  Evaluation of transluminal angioplasty of chronic coronary artery stenosis. Value and limitations assessed in fresh human cadaver hearts.

Authors:  G Lee; R M Ikeda; J A Joye; H G Bogren; A N DeMaria; D T Mason
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

View more
  1 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.